Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Informeren en samen beslissen bij cervicale intra-epitheliale neoplasie
mei 2020 | Gynaecologische oncologie